ARG2 and diabetic kidney disease: Multiple studies have highlighted the potential of inhibition of arginase-2 (Arg-2) as an attractive approach to prevent and manage DKD (You et al., 2015; Xiong et al., 2017; Morris et al., 2011; Raup-Konsavage et al., 2017).